ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) | Grant Type |
Year |
State |
|---|---|---|---|---|
| Choline Kinase and Alkylating Agent Resistance in Refractory Childhood Leukemias | Boston Children's Hospital / Alejandro Gutierrez, MD | Innovation Grants | 2021 | Massachusetts |
| Loss of ER-mitochondria contacts drives therapy resistance in neuroblastoma | Children's Hospital of Philadelphia / Michael Hogarty, MD | Innovation Grants | 2021 | Pennsylvania |
| Targeting tumor associated macrophages in metastatic Ewing sarcoma (ES) | New York Medical College / Mitchell Cairo, MD | Innovation Grants | 2021 | New York |
| A leukemia organoid platform for dissection and targeting of tumor-niche interactions | Columbia Institute for Cancer Genetics / Adolfo Ferrando, MD/PhD | Innovation Grants | 2021 | New York |
| Enhancing TKI Therapy in Ph-Like Leukemia | The Regents of the University of California, Irvine / David Fruman, PhD | Reach Grants | 2022 | California |
| Mechanistic and Therapeutic Development of ATM as a Tumor Cell Selective Target for Radiosensitization in H3K27M DMG | The Regents of the University of Michigan / Meredith Morgan, PhD & Daniel Wahl, MD/PhD | Reach Grants | 2022 | Michigan |
| Novel Therapy for Pediatric Leukemia Patients with NUP98 Translocations | The Regents of the University of Michigan / Jolanta Grembecka, PhD | Reach Grants | 2022 | Michigan |
| Exploiting glypican diversity in neuroblastoma plasticity with bicistronic CAR T cell targeting | Children's Hospital of Philadelphia / Kristopher Bosse, MD | 'A' Award Grants | 2022 | Pennsylvania |
| Epigenetic therapies to concurrently target DIPG tumor cells and harness the immune system | The Regents of the University of Michigan / Sriram Venneti, MD/PhD | R Accelerated Award Grants | 2022 | Michigan |
| Targeting Kinase Inhibitor Induced DNA-Damage Response in Ph-Like ALL | Temple University / Christian Hurtz, PhD | 'A' Award Grants | 2022 | Pennsylvania |